The search giant's $500 million settlement may lead to future troubles.
If you want to dive into the market, look before you leap.
A more-than-skin-deep look at Allergan.
Getting some food and energy into your portfolio.
Novartis' businesses are an investor's delight; J&J's improving but isn't there yet.
Studies find Gilead drugs can help prevent HIV infections, but that may not help sales.
The news looks decidedly mixed.